Phil Charnas’ Post

Tornado - A Bruker Company's groundbreaking High-Throughput Virtual Slit (HTVS™) technology has transformed the use of Raman spectrometers for in-line process monitoring and control!✅ Learn more below about their revolutionary solutions for accurate data analysis, optimizing bioprocessing efficiency, and elevating product excellence⏱📊 #Downstream #Bioprocessing #Biopharma #HTVS #BrukerOptics #TornadoSpectralSystems

Please join us for a #BPIAskTheExpert on "Process Intensification Through Perfused N-1 Bioreactor." One strategy for lowering cost of goods of #biotherapeutics #manufacturing is by dramatically increasing the productivity of the #bioreactor process. Lonza R&D has developed an intensified process that couples a perfused N-1 inoculum bioreactor, enabled by alternating tangential flow filtration, to a fully-automated high inoculation density production stage reactor. This reactor demonstrates substantial increases in bioreactor productivity compared to a low inoculation density control fed-batch process. In this webinar, learn how intensified processes can increase harvest titers and improve space/time yield, how PAT plays a key role in automating and enabling process intensification, and more. Date: Tues., September 10th. Time: 11 AM ET. Featuring: Marissa Dickson, Scientist II, & Brian Hadley, Principal Scientist, Lonza Biologics. Register Now: https://lnkd.in/gtj99Qu7

#UDTechTransfer proudly introduces functionalized PEDOT-Based Biosensors! UD Researchers have developed a new method to make biosensors more stable. This method ensures a strong chemical bond with biologically active molecules, allowing the biosensors to accurately detect a wide range of biological substances with improved sensitivity and specificity over a long period of time. The method utilizes click chemistry-based functionalization. David Martin and the team from the Department of Materials Science and Engineering at the University of Delaware have successfully addressed the challenge of modifying the biosensor surface to achieve consistent and reproducible results. This patent pending technology can revolutionize biosensors and is available for licensing. Learn more about this technology here - https://bit.ly/3VDjgW2 To search all available UD Technologies, please visit: https://bit.ly/3RHnfQ0 #licensingopportunity #techtransfer #techtuesday #Innovation #UDBigideas #Biopharmaceutical #Sensor #CovalentBinding #Electrochemical

#Simulation can be used to optimize (maximize or minimize) chemical concentration gradients in #microfluidic devices. Simulations can help assess and balance the tradeoffs between processing time (flow rate) and gradient length. #diagnostics #biotechnology #pharma #pharmaceuticalindustry #biotech #comsol #chemicalengineering

𝐒𝐢𝐧𝐠𝐥𝐞-𝐔𝐬𝐞 𝐁𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $𝟗.𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟗 𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑷𝑫𝑭 𝑩𝒓𝒐𝒄𝒉𝒖𝒓𝒆 @ https://bit.ly/3WwxR66 The single use bioreactors market is expected to generate a revenue of USD 9.1 billion in 2029, with a revenue of USD 4.4 billion in 2024 to register a CAGR of 15.4%. 𝐊𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐬𝐢𝐧𝐠𝐥𝐞 𝐮𝐬𝐞 𝐛𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Sartorius Danaher Corporation Thermo Fisher Scientific Merck KGaA, Darmstadt, Germany Avantor Repligen Corporation Getinge Eppendorf Parker Hannifin Entegris Saint-Gobain Corning Incorporated Lonza TECNIC Bioprocess Solutions Zacros (Fujimori Kogyo co. ltd.) Kühner Ag OmniBRx Biotechnologies Pvt Ltd New Horizon Biotech PBS Biotech bbi-biotech GmbH ABEC Esco Lifesciences Group Distek, Inc. SATAKE MULTIMIX (M) Cell Culture Company Micro Digital, Inc. Celltainer Biosolutions GmbH Meissner Solida Biotech G&G Technologies PharmNXT Biotech Tofflon Life Science. #SingleUseBioreactors #BiotechInnovation #BioreactorTechnology #DisposableBioreactors #Biomanufacturing #Bioprocessing #PharmaTech #BiotechSolutions #Bioengineering #Biopharma #LifeSciences #SustainableBiotech #BioprocessingEquipment #BiotechIndustry #PharmaceuticalManufacturing

Tangential Flow Filtration industry worth $3.6 billion | CAGR 13.5% Download PDF Brochure: https://lnkd.in/ggXT2s-p The global tangential flow filtration market in terms of revenue was estimated to be worth $1.9 billion in 2023 and is poised to reach $3.6 billion by 2028, growing at a CAGR of 13.5% from 2023 to 2028. 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐩𝐫𝐨𝐟𝐢𝐥𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 Danaher Corporation (US), Merck KGaA (Germany), Sartorius AG (Germany). & Others 𝐎𝐭𝐡𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Bioprocessing, Inc.    Integrated Bioprocessing Research Laboratory      Midwest Bioprocessing Center      Entegris      Pall Corporation      Spectrum Chemical Mfg. Corp.      Antylia Scientific      Nordson MEDICAL      Viant Medical      CPC - Colder Products Company      Qosina      CellFE      OriGen Biomedical      Cell Culture Company      Distek, Inc.      ESCO ASTER PTE LTD        Mitsubishi Chemical Advanced Materials      Systems Ally      Exothera        Solar Biotech        Celonic Group     Essential Pharmaceuticals, LLC      Erbi Biosystems, a part of MilliporeSigma      The Science Advisory Board      BiomatiQ Scientific Pvt. Ltd.      The Cultivated B      OsecoElfab      BIONET      Lennox     UK Biocentre      EKF Diagnostics      Savillex        ValitaCell  lino Biotech AG      Extracellular      Esco Healthcare      Esco Bangladesh      Yulex LLC      3D Biotek, LLC Metenova, a Repligen Company     

Real-time Monitoring of Key Bioprocess Parameters Using MAVERICK In-line Device in Culture Biosciences’ Cloud-connected Bioreactors Bioprocessing 4.0 aims to leverage advanced digital technologies, automation, and data-driven approaches to transform biopharmaceutical production. The data generated utilizing Culture Bioscience’s bioreactors, cloud-based controllers and software console together with MAVERICK, a novel Raman spectroscopy powered in-line PAT device, was found to track closely with off-line measurements for multiple critical process parameters. The use of PAT in bioreactors provides in-line, continuous data about cell culture conditions, thereby enhancing process understanding and enabling precise bioprocess monitoring and control. https://lnkd.in/gtYUue7m #aspenalert #biotech #bioprocess

Single Use Bioprocessing Market Worth $34.9 Billion Download a PDF Brochure: https://lnkd.in/diQaD2z4 Single Use Bioprocessing Market by Product (Equipment (Bioreactors, Mixers, Filtration, Chromatography), Consumables (Filters, Bags, Assemblies, Sensors)), Application, Workflow, Molecule Type (mAbs, Vaccines, CGT, Peptides) - Global Forecast to 2029 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Sartorius, Danaher Corporation, Thermo Fisher Scientific, Merck KGaA, Darmstadt, Germany, Avantor, 3M, Repligen Corporation, Entegris, Getinge, Parker Hannifin, Alfa Laval, Saint-Gobain, Eppendorf , Corning Incorporated, Eaton, Mettler-Toledo Rainin, Porvair PLC (UK), Lonza (Switzerland), ABEC, INC. (US), NewAge Industries (US), PBS Biotech, Inc. (US), Sentinel Process Systems, Inc. (US), Meissner Filtration Products, Inc. (US), SATAKE MultiMix Corporation (Japan), Hamilton Company (US), Membrane Solutions (US), Cole-Parmer Instrument Company, LLC (US), Distek, Inc. (US), Esco Lifesciences Group Ltd. (US), and TECNIC Bioprocess solutions (Spain) Other Companies that are Operating in this Market Globally: ABEC Automated Engineering Services, Inc. High Purity New England PBS Biotech InflexionPoint Clean Water Technology ZETA Ant Teknik ZETA Biosystem Propack Technologies Pvt. Ltd. Distek, Inc. BIONET Pierre Guérin SAS Culture Biosciences INFORS HT BRINOX d.o.o. Eppendorf BiOZEEN ExcellGene SA LOTTE BIOLOGICS Kalbio Global Medika Ellingson LFB Biomanufacturing PIZETA PHARMA S.p.A. #SingleUseBioprocessing #Biotech #HealthTech #Bioprocessing #Pharmaceuticals #MedicalInnovation #Biotechnology #HealthcareTech #LabTech #MarketResearch #Bioprocess #Biomanufacturing #HealthcareInnovation #BiotechIndustry #MedicalResearch #LifeSciences #PharmaTech #BioprocessingTech #FutureOfHealthcare #HealthcareIndustry

𝐒𝐢𝐧𝐠𝐥𝐞 𝐔𝐬𝐞 𝐁𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 𝐄𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐖𝐨𝐫𝐭𝐡 $𝟏𝟎.𝟎 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟖 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐚𝐭 https://lnkd.in/d3wiqyqy The size of global single use bioreactors market in terms of revenue was estimated to be worth $4.2 billion in 2023 and is poised to reach $10.0 billion by 2028, growing at a CAGR of 19.0% from 2023 to 2028. 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Sartorius Danaher Corporation Thermo Fisher Scientific Merck Group Getinge Eppendorf Entegris Avantor Corning Incorporated Esco Bioengineering Kuhner shaker TECNIC Bioprocess Equipment Manufacturing PBS Biotech Satake USA Multimix G&G Technologies ABEC bbi-biotech GmbH REPROCELL Cellexus Distek, Inc. OmniBRx Biotechnologies Pvt Ltd New Horizon Biotech GPC Bio USA Meissner Filtration Products Cell Culture Company #SingleUseBioreactors #Biotechnology #Bioprocessing #PharmaceuticalManufacturing #Biopharmaceuticals #Biomanufacturing #BiotechInnovation #LifeSciences #SustainableBiotech #BioreactorTechnology #CellCulture #BiotechTrends #BioprocessTechnology #BiotechIndustry #InnovativeBiotech #Bioproduction #PharmaTech #BiotechResearch #FutureOfBiotech #Bioengineering

🚀 As the demand for innovative methods in drug discovery and API synthesis soars, the spotlight turns to reactions that form new bonds between aromatic rings. These transformations are pivotal for advancing modern pharmaceuticals. Highlighting a breakthrough, Feiz et al. showcased the efficiency of our H-Cube Mini Plus in synthesizing biaryls through these sophisticated reactions. This cutting-edge instrument simplifies the production of hydrogen gas in situ, eliminating the need for bulky gas storage. Even better? Our H-Cube Mini Plus comes equipped with pre-filled catalyst cartridges (CatCarts) that streamline the process, bypassing the need for catalyst filtration and handling pyrophic materials, ensuring a safer, more efficient workflow. 📄 Dive into the specifics in our comprehensive application note (https://lnkd.in/eJH_ptNV) and explore Feiz et al.’s research in their Nature article (https://lnkd.in/eM_5ENbr). 💬 We want to know! How could these advancements impact your research? How do you think they’ll impact the industry? Let’s discuss in the comments! #chemistry #pharma #innovation #ThalesNano